Electrophysiological changes in diabetic neuropathy: From subclinical alterations to disabling abnormalities

Archives of Physiology and Biochemistry

Volumn 109, Issue 3 SPEC ISS., 2001, Pages 234-240

  Baba, M ^a   Ozaki, I ^b  

^a HIROSAKI UNIVERSITY   (Japan)

^b AOMORI UNIVERSITY OF HEALTH AND WELFARE   (Japan)

Author keywords

Asymptomatic neuropathy; Central conduction time; F wave; Nerve conduction study; Somatosensory evoked potentials

Indexed keywords

ADULT; AGED; CONFERENCE PAPER; DIABETIC NEUROPATHY; DISEASE COURSE; ELECTROPHYSIOLOGY; FEMALE; HUMAN; LATENT PERIOD; MAJOR CLINICAL STUDY; MALE; MOTOR NERVE; NERVE CONDUCTION; NERVE POTENTIAL; PERONEUS NERVE; SENSORY DYSFUNCTION; SENSORY NERVE; SURAL NERVE;

ACTION POTENTIALS; ADULT; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DIABETIC NEUROPATHIES; EVOKED POTENTIALS, SOMATOSENSORY; HUMANS; MIDDLE AGED; NEURAL CONDUCTION; NEUROLOGIC EXAMINATION; PERONEAL NERVE; PILOT PROJECTS; SURAL NERVE;

EID: 0035412483     PISSN: 13813455     EISSN: None     Source Type: Journal    
DOI: 10.1076/apab.109.3.234.11595     Document Type: Conference Paper

References (24)

1. Andersen H, Stalberg E, Falck B (1997): F-wave latency, the most sensitive nerve conduction parameter in patients with diabetes mellitus. Muscle Nerve 20: 1296-1302.
2. Baba M, Sharma AK, Moussa NA, Townsend A (1998): Asymptomatic diabetic neuropathy in Al Ain. Int J Diabetes 6: 64-69.
3. Collier A, Reid W, McInnes A, Cull RE, Ewing DJ, Clarke BF (1988): Somatosensory and visual evoked potentials in insulin-dependent diabetics with mild peripheral neuropathy. Diabetes Res Clin Prac 5: 171-175.
4. Cracco J, Castells S, Mark E (1984): Spinal somatosensory evoked potentials in juvenile diabetes. Ann Neurol 15: 55-58.
5. Dyck PJ (1988): Detection, characterization, and staging of polyneuropathy: assessed in diabetics. Muscle Nerve 11: 21-32.
6. Dyck PJ, Karnes JL, Daube J, O'Brien P, Service J (1985): Clini cal and neuropathological criteria for the diagnosis and staging of diabetic polyneuropathy. Brain 108: 861-880.
7. Dyck PJ, Karnes JL, O'Brien P, Okazaki H, Lais A, England J (1986): The spatial distribution of fiber loss in diabetic polyneuropathy suggesting ischemia. Ann Neurol 19: 440-449.
8. Kimura J (1983): Assessment of individual nerves, in Electrodiagnosis in Diseases of Nerve and Muscle. In: Principles and Clinical Practice. Philadelphia, FA Davis, pp. 105-141.
9. Kohara N, Kimura J, Kaji R, Goto Y, Ishii J, Takiguchi M, Nakai M (2000): F-wave latency serves as the most reproducible measure in nerve conduction studies of diabetic polyneuropathy: multicentre analysis in healthy subjects and patients with diabetic polyneuropathy. Diabetologia 43: 915-921.
10. Krendel DA (1998): Vascular inflammation in proximal diabetic neuropathy (letter). J Neurol 245: 748.
11. Llewelyn JG, Thomas PK, King RHM (1998): Epineurial microvasculitis in proximal diabetic neuropathy. J Neurol 245: 159-165.
12. Nakamura Y, Takahashi M, Kitaguchi M, Kaido M, Imaoka H, Kono S, Tarui S (1989): Clinical utility of somatosensory evoked potentials in diabetes mellitus. Diabetes Res Clin Pract 7: 17-23.
13. Ogawa H, Hosokawa H (1953). The spinal cord. In: Ogawa T, Hosokawa H, eds., The brain in Japanese (Nipponjin no) Tokyo, Kinpara Shuppan, pp. 246-258 (In Japanese).
14. Ozaki I, Suzuki C, Tanosaki M, Baba M, Matsunaga M (2000): Stability of N20 onset or peak latency in median somatosensory evoked potentials. Muscle Nerve 23: 278-282.
15. Ozaki I, Takada H, Baba M, Matsunaga M (1994): Correlation of somatosensory central conduction time with height. Neurology 44: 1115-1119.
16. Ozaki I, Takada H, Shimamura H, Baba M, Matsunaga M (1996): Central conduction in somatosensory evoked potentials. Comparison of ulnar and median data and evaluation of onset versus peak methods. Neurology 47: 1229-1304.
17. Palma V, Serra LL, Armentano V, Serra FP, Nolfe G (1994): Somatosensory evoked potentials in non-insulin-dependent diabetics with different degrees of neuropathy. Diabetes Res Clin Pract 25: 91-96.
18. Partanen J, Niskanen L, Lehtinen J. Mervaala E, Siitonen O, Uusitupa M (1995): Natural history of peripheral neuropathy in patients with non-insulin-dependent diabetes mellitus. N Engl J Med 333: 89-84.
19. Pirat J (1978): Diabetes mellitus and its degenerative complications: a prospective study of 4,400 patients observed between 1947 and 1973, part 1 and 2. Diabetes Care 1: 252-263.
20. Pozzessere G, Rizzo PA, Valle E, Mollica MA, Meccia A, Morano S, Di Mario U, Andeani D, Morcutti C (1988): Early detection of neurological involvement in IDDM and NIDDM. Multimodal evoked potentials versus metabolic control. Diabetes Care 11: 473-480.
21. Redmond JMT, McKenna MJ, Feingold M (1992): Sensory testing versus nerve conduction velocity in diabetic polyneuropathy. Muscle Nerve 15: 1334-1339.
22. Slager UT (1978): Diabetic myelopathy. Arch Pathol Lab Med 102: 467-469.
23. Tanosaki M, Ozaki I, Shimamura H, Baba M, Matsunaga M (1999): Effects of aging on central conduction in somatosensory evoked potentials: evaluation of onset versus peak methods. Clin Neurophysiol 110: 2094-2103.
24. The Diabetes Control and Complication Trial Research Group (1993): The effect of intensive treatment of diabetes on the development and progression of long-term complication in insulin-dependent diabetes mellitus. N Engl J Med 329: 977-986.